medicines substitution
Department flags drug substitution rules as doctors raise concerns
Survey reveals pharmacists are switching patients to bioequivalent brands of prescribed medicines despite GPs ticking ‘no substitution allowed’ Pharmacists are being warned that they could find themselves in breach of …
Pharmacists need regulators’ trust for substitution
Patients face increased out-of-pocket costs due to regulations preventing pharmacists from making clinical decisions to substitute prescribed medications when supply shortages hit Regulatory changes are needed to give pharmacists greater …
Red tape hinders access to medicines
Women are being denied access to readily available HRT medications due to “unnecessary red tape” Senate committee told Authorising pharmacists to substitute strengths and brands of hormone replacement therapy (HRT) …
PBS issues substitution update
Bufomix Easyhaler 400/12 will become substitutable with other PBS-listed brands from 1 July The Pharmaceutical Benefits Scheme (PBS) has confirmed an error preventing Bufomix Easyhaler 400/12 (budesonide 400 microgram/actuation + …
Zactin Tabs shortage set to continue
TGA extends fluoxetine substitution instrument in response to ongoing manufacturing issues Supply shortages impacting Zactin Tabs (fluoxetine 20mg dispersible tablets) are expected to continue until 30 June 2024, the medication’s …
World news wrapup – 23 May 2024
British pharmacists call for authority to substitute medications; pharmacist plans return to Gaza days after evacuations; Candian patients want more from their pharmacy. London, UK: Pharmacists in the UK are …
TGA issues SSSI for abatacept
Pharmacists authorised to substitute Orencia 125mg/mL products to deal with shortages The Therapeutic Goods Administration (TGA) has issued a Serious Scarcity Substitution Instrument (SSSI) in response to shortages of both …
Antibiotic substitution arrangement in force
New amoxicillin substitution amendments introduced as health system tries to deal with the ongoing shortage of the medicine The federal Department of Health and Aged Care has announced amendments to …
Supply ‘constrained’ but improving
Substitution instrument extended for abatacept, while others end The Serious Scarcity Substitution Instrument (SSSI) for abatacept (Orencia), originally set to expire on 30 April, has been extended until 30 June. …
A new substitution
Abatacept added to list of pharmacist-substitutable medicines due to scarcity From today (9 Feb) until 30 April 2022, community pharmacists can interchangeably substitute abatacept syringe (Orencia) and abatacept autoinjector (Orencia …
Pharmacist substitution extended
Supply is improving for tocilizumab (Actemra) products but disruptions to some products will continue beyond this month, warns Roche Availability of tocilizumab (Actemra) products is “improving” and supply should be …
Scarcity drives pharmacy substitution
Community pharmacists are now able to substitute Actemra formulations without prior prescriber approval, due to serious shortages Two tocilizumab (Actemra) formulations are now effectively interchangeable at the pharmacy level after …